Skip to main content

Month: August 2025

La-Z-Boy Incorporated Announces Participation In Goldman Sachs 32nd Annual Global Retailing Conference

MONROE, Mich., Aug. 28, 2025 (GLOBE NEWSWIRE) — La-Z-Boy Incorporated (NYSE: LZB), a global leader in the retail and manufacture of residential furniture, today announced the company will participate in a fireside chat at the Goldman Sachs 32nd Annual Global Retailing Conference in New York. The presentation will be webcast live on Thursday, September 4, 2025, at 1:10 p.m. ET and archived on the Company’s investor relations website at https://lazboy.gcs-web.com/. Investor Relations Contact:Mark Becks, CFA, (734) 457-9538mark.becks@la-z-boy.com About La-Z-Boy:La-Z-Boy Incorporated brings the transformational power of comfort to people, homes, and communities around the world – a mission that began when its founders invented the iconic recliner in 1927. Today, the company operates as a vertically integrated furniture retailer...

Continue reading

SEGG Media backed Veloce Media Group boasts strong quarter with blue-chip partnerships for newly acquired Quadrant

A Media Snippet accompanying this announcement is available by clicking on this link. LONDON, Aug. 28, 2025 (GLOBE NEWSWIRE) — SEGG Media Corporation (NASDAQ: SEGG, LTRYW) (“SEGG Media” or the “Company”), a leading technology company owning Sports.com, Concerts.com, and Lottery.com, continues to see positive growth across its portfolio following its strategic investment into Veloce Media Group (“Veloce”), and Veloce’s subsequent acquisition of Quadrant. Veloce is one of the fastest-growing platforms at the intersection of sport, gaming and digital media. Following the announcement of the investment into Veloce earlier this year, the partnership is already achieving growth across competitive operations, digital media platforms, and immersive content divisions. Most notably, in the integration and expansion of creator-led brand Quadrant,...

Continue reading

YY Group Signs Strategic MOU with Keenon Robotics

Singapore , Aug. 28, 2025 (GLOBE NEWSWIRE) — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group,” “YYGH,” or the “Company”), a global leader in on-demand workforce solutions and integrated facility management (IFM), today announced the signing of a Memorandum of Understanding (MOU) with KEENON (Hong Kong) Limited (“Keenon”), a globally renowned leading provider of service robotics. This MOU builds on YY Group’s recently launched robotics integration initiative, aimed at enhancing service consistency, safety, and operational efficiency across high-impact service lines. Strategic Robotics Expansion YY Group’s robotics integration initiative is designed to transform service delivery in high-impact sectors such as hospitality, healthcare, and facilities management. The rollout includes robotic dish-servers and cleaners. Deployment...

Continue reading

Abercrombie & Fitch Named Official Fashion Partner of the Dallas Cowboys

Abercrombie brings its signature style to the Cowboys and their fansAbercrombie & Fitch Partners with Dallas CowboysCeeDee Lamb for Abercrombie & FitchAbercrombie & Fitch Partners with Dallas CowboysAbercrombie & Fitch Partners with Dallas CowboysNEW ALBANY, Ohio, Aug. 28, 2025 (GLOBE NEWSWIRE) — Abercrombie & Fitch (Abercrombie), a division of Abercrombie & Fitch Co. (NYSE: ANF), today announced a multi-year partnership naming the brand as an Official Fashion Partner of the Dallas Cowboys and the Dallas Cowboys Cheerleaders. This partnership is the first of its kind between Abercrombie and a National Football League team. This industry-first move comes on the heels of the NFL naming Abercrombie an Official Fashion Partner, a first for the league. This new partnership builds on the...

Continue reading

Vantage Drilling International Ltd. Reports Second Quarter 2025 Results

Dubai, Aug. 28, 2025 (GLOBE NEWSWIRE) — Vantage Drilling International Ltd. (“Vantage” or the “Company”) reported a net loss attributable to shareholders of approximately $16.0 million or $1.20 per diluted share for the three months ended June 30, 2025, based on the weighted average shares outstanding, as compared to a net loss attributable to shareholders of approximately $14.2 million or $1.07 per diluted share for the three months ended June 30, 2024. As of June 30, 2025, Vantage had approximately $52.9 million in cash, including $9.5 million in pre-funding for upgrading the Tungsten Explorer, $2.4 million in restricted cash and $6.9 million pre-funded by our Managed Services customers for near-term obligations. In comparison, as of December 31, 2024, Vantage had $89.6 million in cash, including $20.0 million in...

Continue reading

LPL Financial Welcomes Concentric Wealth Management

SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that the advisors of Concentric Wealth Management have joined LPL Financial’s broker-dealer, Registered Investment Advisor (RIA). They reported serving approximately $715 million in advisory, brokerage and retirement plan assets* and join LPL from Avantax by Cetera. Based in Cincinnati, Ohio, the team is led by Patrick Burke, CPA® and Matt Tarka, AAMS®, CRPS®. The company started as an accounting firm over 40 years ago and expanded to wealth management 15 years ago. The advisors work with a broad spectrum of clients including business owners, retirees, and emerging affluent households. They also serve a large niche of other professional service providers. “We are a one-stop-shop for our clients regardless of their stage of life. We provide highly skilled...

Continue reading

Can-Fite Reports H1 2025 Financial Results and Clinical Update

Ramat Gan, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced financial results and clinical updates for H1, 2025. Clinical & Development Milestones Achieved Namodenoson Drug Candidate – Pancreatic Cancer Phase 2a Study with Can-Fite’s Namodenoson Achieved Over 50% Enrollment Milestone The Phase 2a study (NCT06387342) is a multicenter, open-label trial enrolling patients with advanced pancreatic adenocarcinoma whose disease has progressed following at least one line of prior therapy. The study is evaluating the safety (primary endpoint), clinical activity, and pharmacokinetics (PK) of Namodenoson in this patient population. Participants...

Continue reading

CF Energy Announces Financial Results For the Three-month and Six-month periods ended June 30, 2025

TORONTO, Aug. 28, 2025 (GLOBE NEWSWIRE) — CF Energy Corp. (TSX-V: CFY) (“CF Energy” or the “Company”, together with its subsidiaries, the “Group”), an energy provider in the People’s Republic of China (the ”PRC” or “China”), announces that the Company has filed its unaudited interim consolidated financial results for the three-month and six-month periods ended June 30, 2025.   The unaudited condensed interim consolidated financial statements and Management’s Discussion and Analysis (“MD&A”) can be downloaded from www.sedarplus.com or from the Company’s website at www.cfenergy.com. The unaudited condensed interim consolidated financial statements have been prepared in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board (“IASB”) (collectively, “IFRS Accounting Standards”)....

Continue reading

Alarum Technologies Announces Second Quarter 2025 Results

Deepening collaborations with major global customers while accelerating investments intechnology and talent to cement Alarum’s key positioning in the AI value chain Q2 2025 revenues of $8.8 million, net profit of $0.3 million, and Adjusted EBITDA of $1.0 million TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of web data collection solutions, today announced financial results for the six- and three-month periods ended June 30, 2025. Management Commentary “Our focus and progress this quarter, as well as our outlook, are mainly driven by very strong demand for data from major global players in the artificial intelligence (AI) segment for training large language and other foundational models,” commented Shahar Daniel, Chief Executive Officer...

Continue reading

NurExone Biologic Inc. Announces Second Quarter 2025 Financial Results

TORONTO and HAIFA, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system injuries, is pleased to announce its financial results for the second quarter ended June 30, 2025 (“Q2”), and provide a corporate update on its recent activities and upcoming milestones. The Company’s full set of unaudited condensed interim consolidated financial statements for the six months ended June 30, 2025, and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.nurexone.com and its SEDAR+ profile at www.sedarplus.ca. Key Business HighlightsC$2.3 million raised through Private Placement: On April 10, 2025, NurExone...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.